BioCardia Inc (BCDA)
2.40
+0.01
(+0.42%)
USD |
NASDAQ |
Nov 04, 13:14
BioCardia Total Assets (Quarterly): 2.89M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.89M |
| March 31, 2024 | 2.679M |
| December 31, 2023 | 2.987M |
| September 30, 2023 | 3.747M |
| June 30, 2023 | 6.389M |
| March 31, 2023 | 7.128M |
| December 31, 2022 | 9.793M |
| September 30, 2022 | 9.179M |
| June 30, 2022 | 11.27M |
| March 31, 2022 | 12.84M |
| December 31, 2021 | 15.72M |
| September 30, 2021 | 17.33M |
| June 30, 2021 | 20.22M |
| March 31, 2021 | 23.31M |
| December 31, 2020 | 23.42M |
| September 30, 2020 | 9.502M |
| June 30, 2020 | 13.13M |
| March 31, 2020 | 4.384M |
| December 31, 2019 | 7.678M |
| September 30, 2019 | 10.68M |
| June 30, 2019 | 2.716M |
| March 31, 2019 | 5.157M |
| December 31, 2018 | 6.417M |
| September 30, 2018 | 5.556M |
| June 30, 2018 | 7.661M |
| Date | Value |
|---|---|
| March 31, 2018 | 10.41M |
| December 31, 2017 | 13.54M |
| September 30, 2017 | 15.86M |
| June 30, 2017 | 17.76M |
| March 31, 2017 | 19.78M |
| December 31, 2016 | 22.08M |
| September 30, 2016 | 19.48M |
| June 30, 2016 | 14.02M |
| March 31, 2016 | 13.95M |
| December 31, 2015 | 13.88M |
| September 30, 2015 | 13.78M |
| June 30, 2015 | 13.70M |
| March 31, 2015 | 13.62M |
| December 31, 2014 | 13.54M |
| September 30, 2014 | 13.49M |
| June 30, 2014 | 13.44M |
| March 31, 2014 | 13.38M |
| December 31, 2013 | 13.33M |
| September 30, 2013 | 13.31M |
| June 30, 2013 | 13.28M |
| March 31, 2013 | 13.28M |
| December 31, 2012 | 13.30M |
| September 30, 2012 | 13.39M |
| June 30, 2012 | 12.94M |
| March 31, 2012 | 13.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.679M
Minimum
Mar 2024
23.42M
Maximum
Dec 2020
10.72M
Average
9.502M
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.205B |
| Theriva Biologics Inc | 42.39M |
| Zevra Therapeutics Inc | 144.41M |
| PetIQ Inc | 894.39M |
| Instil Bio Inc | 294.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.851M |
| Shareholders Equity (Quarterly) | -1.961M |
| Current Ratio | 0.3864 |